Early high-dose rhEPO fails to improve neurodevelopment in very preterm infants

Very preterm infants do not gain protection against neurodevelopmental delay with early prophylactic high-dose recombinant human erythropoietin, researchers report.

Source: MedWire News - May 18, 2016 Category: Consumer Health News Tags: Neurology Source Type: news